300832 ShenZhen New Industries Biomedical Engineering

Watchlist

70.90
+1.40+2.01%

Market Closed Dec 12 15:00 CST

55.71BMarket Cap30.11P/E (TTM)

About ShenZhen New Industries Biomedical Engineering Company

The company was founded in 1995 and is a national high-tech enterprise specializing in R&D, production, sales and service of in vitro diagnostic products. Since its establishment, the company has been focusing on research in the field of chemiluminescence immunoassay. After more than ten years of dedicated efforts, the company successfully launched the first fully automatic chemiluminescence immunoassay analyzer in China in September 2008. The company is mainly engaged in R&D, production, sales and customer service of products in the field of in vitro diagnosis. The company's main products include: diagnostic instruments and diagnostic reagents used in conjunction with them. Corporate honors: Famous trademarks in Guangdong Province, most influential listed companies, national high-tech industrialization demonstration engineering units, etc.

Company Profile

Short Name-A新产业

Symbol-A300832

Company NameShenZhen New Industries Biomedical Engineering Co.,Ltd.

Listing DateMay 12, 2020

Issue Price31.39

Shares Offered41.20M share(s)

FoundedDec 15, 1995

Legal Representativewei rao

General Managerwei rao

Secretarylei zhang

Accounting FirmZheng Dan Zhiyuan (Shenzhen) Certified Public Accountants (Special General Partnership)

Securities Representativeyujie li

Legal CounselBeijing Guofeng (Shenzhen) Law Firm

Employees2756

Phone0755-86540062

Office AddressNew Industrial Biology Building, No. 23, Jinxiu East Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen

Zip Code518118

Registered Address21st Floor, New Industrial Biology Building, No. 23 Jinxiu East Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen

Fax0755-26654800

Emailsnibeinfo@snibe.cn

Websitehttp://www.snibe.com

Business License440301103645899

BusinessGeneral business projects: Import and export business (operating in accordance with the provisions of Shenzhen Trade Regulations No. 2002-452 “Qualification Certificate”); software research and development (computer production only, excluding production line production); production and sale of non-medical devices supporting licensed medical device products; leasing of own property; property management; software and information technology services. Technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; first-class medical device sales; specialty chemical product manufacturing (excluding hazardous chemicals); specialty chemical product sales (excluding hazardous chemicals); information consulting services (excluding licensing information consulting services); software sales; instrument manufacturing; instrument sales; electronic product sales; special equipment manufacturing (excluding licensed professional equipment manufacturing); special equipment repair; medical equipment leasing; general cargo warehousing services (excluding hazardous chemicals, etc.); total quality 4.5 tons Road cargo transportation (excluding network freight and dangerous goods) by ordinary freight vehicles as well as the following; investment activities are carried out with own capital. (With the exception of projects subject to approval according to law, business activities are carried out independently in accordance with the law on the basis of a business license). Licensed business projects: Class I medical device production; Class II medical device production; Class II medical device sales; Class III medical device production; Class III medical device management; veterinary drug production; veterinary drug business. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments. Specific business projects are subject to the relevant department's approval documents or licenses)

Company Executives

Name
Position
Salary

wei rao
Chairman, Directors, General Manager, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee
4.59M

xu li
Directors, Audit Committee Member
--

heming weng
Directors, Strategy Committee Member
--

jie rao
Directors, Strategy Committee Members, Member of the Remuneration and Assessment Committee
--

qianhui wu
Independent Directors, Member of the Remuneration and Assessment Committee, Strategy Committee Member, Chairman of the Nomination Committee
120.00K